Although the approximate amount of receptors may determine the effect [10], the relationship of type-I IFNs receptor expression with the anti-tumour effect of IFN-α/β in pancreatic cancer cell lines is not established. This evidence concerns the gene IFNA2 and familial pancreatic carcinoma.